{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:59:49Z","timestamp":1715594389092},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1161\/hypertensionaha.110.166876","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T03:32:39Z","timestamp":1298345559000},"page":"667-669","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Dual Endothelin-Converting Enzyme\/Neutral Endopeptidase Inhibition"],"prefix":"10.1161","volume":"57","author":[{"given":"Neeraj","family":"Dhaun","sequence":"first","affiliation":[{"name":"From the Clinical Pharmacology Unit (N.D., D.J.W.), British Heart Foundation (BHF) Centre of Research Excellence (CoRE), University of Edinburgh, the Queen's Medical Research Institute, Edinburgh, United Kingdom; Department of Renal Medicine (N.D.), Royal Infirmary of Edinburgh, Edinburgh, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Webb","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (N.D., D.J.W.), British Heart Foundation (BHF) Centre of Research Excellence (CoRE), University of Edinburgh, the Queen's Medical Research Institute, Edinburgh, United Kingdom; Department of Renal Medicine (N.D.), Royal Infirmary of Edinburgh, Edinburgh, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.8.2863"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0840485"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/348730a0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/348732a0"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199322008-00008"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.8.752"},{"key":"e_1_3_2_8_2","first-page":"653","article-title":"Profile of past and current clinical trials involving endothelin receptor antagonists: the novel \u201c-sentan\u201d class of drug","volume":"231","author":"Battistini B","year":"2006","unstructured":"Battistini B, Berthiaume N, Kelland NF, Webb DJ, Kohan DE. Profile of past and current clinical trials involving endothelin receptor antagonists: the novel \u201c-sentan\u201d class of drug. Soc Exp Biol Med. 2006;231:653\u2013695.","journal-title":"Soc Exp Biol Med"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.160952"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-32967-6_9"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-128-3-1465"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.23.2323"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.163972"},{"key":"e_1_3_2_14_2","first-page":"170","article-title":"Unraveling the mystery of Goldblatt hypertension","volume":"13","author":"Navar LG","year":"1998","unstructured":"Navar LG, Zou L, Von Thun A, Tarng Wang C, Imig JD, Mitchell KD. Unraveling the mystery of Goldblatt hypertension. News Physiol Sci. 1998;13:170\u2013176.","journal-title":"News Physiol Sci"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000166208.12297.8d"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000168944.29525.da"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.110.166876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:15:41Z","timestamp":1715591741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.110.166876"}},"subtitle":["A Novel Treatment for Renovascular Hypertension Beyond Blood Pressure Lowering?"],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.110.166876"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.110.166876","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"2011-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}